Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study

Show simple item record

dc.contributor.author Prasad, D. S.
dc.contributor.author Kabir, Zubair
dc.contributor.author Devi, K. Revathi
dc.contributor.author Dash, A. K.
dc.contributor.author Das, B. C.
dc.date.accessioned 2014-07-23T09:28:48Z
dc.date.available 2014-07-23T09:28:48Z
dc.date.issued 2014-06
dc.identifier.citation PRASAD, D. S., KABIR, Z., DEVI, K. R., DASH, A. K. & DAS, B. C. 2014. Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study. Open Heart, 1, e000100. http://dx.doi.org/10.1136/openhrt-2014-000100 en
dc.identifier.volume 1 en
dc.identifier.issued 1 en
dc.identifier.startpage e000100 en
dc.identifier.issn 2053-3624
dc.identifier.uri http://hdl.handle.net/10468/1597
dc.identifier.doi 10.1136/openhrt-2014-000100
dc.description.abstract Introduction: Atherosclerotic cardiovascular disease is a significant modifiable complication in patients with diabetes and subclinical atherosclerosis is considered a surrogate marker of future vascular events. The clustering of cardiometabolic-risk factors in patients with diabetes and cardiovascular disease is increasingly being recognised. Recent evidence indicates that 20–50% of asymptomatic patients with diabetes may have silent coronary heart disease. However, the identification of subclinical atherosclerosis and silent myocardial ischaemia in patients with diabetes has been less well-explored, especially in low-resource population settings where cost-effective non-invasive clinical tools are available. The objective of this study is to identify patients with physician-diagnosed diabetes who are at risk of developing future cardiovascular events measured as subclinical atherosclerosis and silent myocardial ischaemia in an urban population of Eastern India.Methods and analysis This is a cross-sectional clinico-observational study. A convenience sampling of approximately 350 consecutive patients with type 2 diabetes based on predefined inclusion and exclusion criteria will be identified at an urban diabetes center. This estimated sample size is based on an expected prevalence of silent myocardial ischaemia of 25% (± 5%), we computed the required sample size using OpenEpi online software assuming an α level of 0.05 (95% CI) to be 289. On factoring 20% non-response the estimated sample size is 350. Previously validated questionnaire tools and well-defined clinical, anthropometric and biochemical measurements will be utilised for data collection. The two primary outcomes—subclinical atherosclerosis and silent myocardial ischaemia will be measured using carotid intima-media thickness and exercise tolerance testing, respectively. Descriptive and multivariate logistic regression statistical techniques will be employed to identify ‘at risk’ patients with diabetes, and adjusted for potential confounders. Ethics and dissemination: Ethical approval was granted by the institutional review board of Kalinga Institute of Medical Sciences, Bhubaneshwar, India. Data will be presented at academic fora and published in peer-reviewed journals. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher BMJ Publishing Group en
dc.relation.uri http://openheart.bmj.com/content/1/1/e000100.abstract
dc.rights This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/http://creativecommons.org/licenses/by-nc/3.0/ en
dc.rights.uri http://creativecommons.org/licenses/by-nc/3.0/ en
dc.subject Artherosclerosis en
dc.subject Silent myocardial ischaemia en
dc.subject Type 2 diabetes en
dc.subject Protocol en
dc.title Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study en
dc.type Article (non peer-reviewed) en
dc.internal.authorcontactother Zubair Kabir, Epidemiology & Public Health, University College Cork, Cork, Ireland. +353-21-490-3000 Email: z.kabir@ucc.ie en
dc.internal.availability Full text available en
dc.date.updated 2014-06-13T18:34:24Z
dc.description.version Published Version en
dc.internal.rssid 259136983
dc.description.status Not peer reviewed en
dc.identifier.journaltitle BMJ Open en
dc.internal.copyrightchecked Yes en
dc.internal.licenseacceptance Yes en
dc.internal.IRISemailaddress z.kabir@ucc.ie en


Files in this item

This item appears in the following Collection(s)

Show simple item record

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/http://creativecommons.org/licenses/by-nc/3.0/ Except where otherwise noted, this item's license is described as This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/http://creativecommons.org/licenses/by-nc/3.0/
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement